Exact Mass: 457.0436

Exact Mass Matches: 457.0436

Found 46 metabolites which its exact mass value is equals to given mass value 457.0436, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-(3,5-Dichloropyrid-4-yl)-(1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl)glyoxylic acid amide

N-(3,5-dichloropyridin-4-yl)-2-{1-[(4-fluorophenyl)methyl]-5-hydroxy-1H-indol-3-yl}-2-oxoacetamide

C22H14Cl2FN3O3 (457.0396)


   

CDP-N-methylethanolamine

2-(methylazaniumyl)ethyl ({[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate

C12H19N4O11P2 (457.0526)


Cdp-n-methylethanolamine is soluble (in water) and a moderately acidic compound (based on its pKa). Cdp-n-methylethanolamine can be found in a number of food items such as cloudberry, jostaberry, wax gourd, and mexican oregano, which makes cdp-n-methylethanolamine a potential biomarker for the consumption of these food products.

   
   
   
   

7-Methylguanosine 5-diphosphate

7-Methylguanosine 5-diphosphate

C11H17N5O11P2 (457.04)


   
   
   

SC-51322

8-chloro-2-[3-[(2-furanylmethyl)thio]-1-oxopropyl]hydrazide, dibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid

C22H20ClN3O4S (457.0863)


   

Lucifer yellow CH

Lucifer Yellow CH dilithium salt

C13H9Li2N5O9S2 (457.0162)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

Omega Chrome Black Blue G

Omega Chrome Black Blue G

C18H13ClN3NaO6S (457.0111)


   

5(6)-azidofluorescein diacetate

5(6)-azidofluorescein diacetate

C24H15N3O7 (457.091)


   

TETRAAMMINEPLATINUM(II) HYDROGEN PHOSPHATE

TETRAAMMINEPLATINUM(II) HYDROGEN PHOSPHATE

H16N4O8P2Pt (457.0091)


   
   

3-chloro-2,6-difluorobenzylamine

3-chloro-2,6-difluorobenzylamine

C26H21BrNP (457.0595)


   

2-(5-bromo-2-methoxyphenyl)-3-(4-ethoxyphenyl)sulfonyl-1,3-thiazolidine

2-(5-bromo-2-methoxyphenyl)-3-(4-ethoxyphenyl)sulfonyl-1,3-thiazolidine

C18H20BrNO4S2 (457.0017)


   

4-Bromo-N-(4-bromophenyl)-N-(4-(sec-butyl)phenyl)aniline

4-Bromo-N-(4-bromophenyl)-N-(4-(sec-butyl)phenyl)aniline

C22H21Br2N (457.0041)


   

3-[5-tert-butyl-2-[(2,4-dichlorophenyl)methyl]pyrazol-3-yl]-4-phenyl-1H-1,2,4-triazole-5-thione

3-[5-tert-butyl-2-[(2,4-dichlorophenyl)methyl]pyrazol-3-yl]-4-phenyl-1H-1,2,4-triazole-5-thione

C22H21Cl2N5S (457.0895)


   

Ponazuril

Ponazuril

C18H14F3N3O6S (457.0555)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

ethyl 3,4-dihydro-<<5-(methylsulfonyl)benzothiazol-2-yl>methyl>-4-oxo-1-phthalazineacetate

ethyl 3,4-dihydro-<<5-(methylsulfonyl)benzothiazol-2-yl>methyl>-4-oxo-1-phthalazineacetate

C21H19N3O5S2 (457.0766)


   

4,4-Dibromo-4-tert-butyltriphenylamine

4,4-Dibromo-4-tert-butyltriphenylamine

C22H21Br2N (457.0041)


   

Cloxacillin Sodium

Cloxacillin Sodium

C19H17ClN3NaO5S (457.0475)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

6-bromo-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine

6-bromo-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine

C21H14BrClFN3O (456.9993)


   

N-(4,4,5,5,6,6,7,7,8,8,9,9,9-Tridecafluorononyl)maleimide

N-(4,4,5,5,6,6,7,7,8,8,9,9,9-Tridecafluorononyl)maleimide

C13H8F13NO2 (457.0347)


   

5-[5,6-Bis(Methyloxy)-1h-Benzimidazol-1-Yl]-3-{[1-(2-Chlorophenyl)ethyl]oxy}-2-Thiophenecarboxamide

5-[5,6-Bis(Methyloxy)-1h-Benzimidazol-1-Yl]-3-{[1-(2-Chlorophenyl)ethyl]oxy}-2-Thiophenecarboxamide

C22H20ClN3O4S (457.0863)


   

Guanosine 5-(trihydrogen diphosphate), 7-methyl-, inner salt

Guanosine 5-(trihydrogen diphosphate), 7-methyl-, inner salt

C11H17N5O11P2 (457.04)


   

3-[5-[(3,4-Dichlorophenyl)methylthio]-4-ethyl-1,2,4-triazol-3-yl]-1-phenyl-4-pyridazinone

3-[5-[(3,4-Dichlorophenyl)methylthio]-4-ethyl-1,2,4-triazol-3-yl]-1-phenyl-4-pyridazinone

C21H17Cl2N5OS (457.0531)


   

N-[5-[[2-(4-acetamidoanilino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-3-methoxybenzamide

N-[5-[[2-(4-acetamidoanilino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-3-methoxybenzamide

C20H19N5O4S2 (457.0878)


   

Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]

Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]

C17H19N3O6S3 (457.0436)


   

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronate)-6-O-sulfonato-D-galactopyranose(2-)

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronate)-6-O-sulfonato-D-galactopyranose(2-)

C14H19NO14S-2 (457.0526)


   

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronate)-4-O-sulfonato-D-galactopyranose(2-)

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronate)-4-O-sulfonato-D-galactopyranose(2-)

C14H19NO14S-2 (457.0526)


   

4-deoxy-Delta(4)-beta-D-GlcpA2S-(1->3)-beta-D-GalpNAc(2-)

4-deoxy-Delta(4)-beta-D-GlcpA2S-(1->3)-beta-D-GalpNAc(2-)

C14H19NO14S-2 (457.0526)


   

4-deoxy-beta-D-Delta4-GlcAp-(1->3)-D-GlcNAc6S

4-deoxy-beta-D-Delta4-GlcAp-(1->3)-D-GlcNAc6S

C14H19NO14S-2 (457.0526)


   

4-deoxy-beta-D-Delta4-GlcAp-(1->4)-D-GalNAc6S

4-deoxy-beta-D-Delta4-GlcAp-(1->4)-D-GalNAc6S

C14H19NO14S-2 (457.0526)


   

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc6S(2-)

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc6S(2-)

C14H19NO14S-2 (457.0526)


   

Indole chloropyridinyl-ester derived, 7b

Indole chloropyridinyl-ester derived, 7b

C20H12ClN3O6S (457.0135)


   

2-[(4-Bromophenoxy)methyl]-5-[2-(3,4-dimethoxyphenyl)ethylamino]-4-oxazolecarbonitrile

2-[(4-Bromophenoxy)methyl]-5-[2-(3,4-dimethoxyphenyl)ethylamino]-4-oxazolecarbonitrile

C21H20BrN3O4 (457.0637)


   
   

2-[5-(1-pyrrolidinylsulfonyl)-2-thiophenyl]-N-[2-(4-sulfamoylphenyl)ethyl]acetamide

2-[5-(1-pyrrolidinylsulfonyl)-2-thiophenyl]-N-[2-(4-sulfamoylphenyl)ethyl]acetamide

C18H23N3O5S3 (457.08)


   

2-[2-chloro-4-(2,3-dihydroindol-1-ylsulfonyl)phenoxy]-N-(2-pyridinylmethyl)acetamide

2-[2-chloro-4-(2,3-dihydroindol-1-ylsulfonyl)phenoxy]-N-(2-pyridinylmethyl)acetamide

C22H20ClN3O4S (457.0863)


   

N-[(E)-(4-bromo-5-methylfuran-2-yl)methylideneamino]-2-(4-methoxy-N-methylsulfonylanilino)propanamide

N-[(E)-(4-bromo-5-methylfuran-2-yl)methylideneamino]-2-(4-methoxy-N-methylsulfonylanilino)propanamide

C17H20BrN3O5S (457.0307)


   

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronate)-4-O-sulfonato-beta-D-galactopyranose(2-)

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronate)-4-O-sulfonato-beta-D-galactopyranose(2-)

C14H19NO14S-2 (457.0526)


   

(6E)-5-imino-6-[[1-(2-methoxyphenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-3-methylsulfonyl-[1,2,4]thiadiazolo[4,5-a]pyrimidin-7-one

(6E)-5-imino-6-[[1-(2-methoxyphenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-3-methylsulfonyl-[1,2,4]thiadiazolo[4,5-a]pyrimidin-7-one

C20H19N5O4S2 (457.0878)


   

MB710

MB710

C16H16IN3O3S (456.9957)


MB710, an aminobenzothiazole derivative, is a stabilizer of oncogenic p53 mutation Y220C. MB710 binds tightly to the Y220C pocket and stabilizes p53-Y220C, with a Kd of 4.1?μM. MB710 shows anticancer activity in p53-Y220C cell lines[1].

   

n-[10,10-dichloro-2-(6,6-dichlorohexyl)-1-methoxy-1-oxodec-9-en-7-yn-3-yl]ethanimidic acid

n-[10,10-dichloro-2-(6,6-dichlorohexyl)-1-methoxy-1-oxodec-9-en-7-yn-3-yl]ethanimidic acid

C19H27Cl4NO3 (457.0745)


   

12-(3,4-dihydroxyphenyl)-7,8,16,17-tetrahydroxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17,20-nonaen-3-one

12-(3,4-dihydroxyphenyl)-7,8,16,17-tetrahydroxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17,20-nonaen-3-one

C25H15NO8 (457.0798)